Loading…
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹44,835Admitted-Finance 1ST AND 2ND FLOOR NXT TOWER 2 EMBASSY MANYATA BUSINESS PARK NAGAVARA VILLAGE KASABA HOBLI BANGALORE KARNATAKA INDIA 560045 | BANGALORE | BANGALORE | KARNATAKA | 560045 | L1 | Admitted-Finance |
| Sl No | Description | Qty | Unit | Novo Nordisk India Private Limited L1 |
|---|---|---|---|---|
| 1.00 | Factor-IX (Extended Half Life), 500IU
(N9GP Glycopegylated,
Extended half life 90-111 hrs) | 1 | Per vial | 42,700 ₹44,835 Lowest |
Tender Value
Refer Docs
EMD Value
₹1 L
Closing Date
27 Jun 2022, 4:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Managing Director -JKMSCL
OFFICE OF JKMSCL
ANTI HAEMOPHLLIC FACTOR
2022_HME_171687_1
JKMSCL/F-IX-EHL /2022/532 DATED 31/05/2022
Open Tender
Medicines
Item Wise
730 days
Jammu / Srinager
Please refer Tender documents.
2 documents required · 2 mandatory
₹10,000
Yes
As per NIT through NEFT
₹1 L
Yes
1 Aug 2022
31 May 2022
28 Jun 2022
31 May 2022
27 Jun 2022
31 May 2022
180 days
Factor-IX (Extended Half Life), 500IU (N9GP Glycopegylated, Extended half life 90-111 hrs)
stage.html
html • 0.03 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .